LONDON, Nov. 28, 2022 /PRNewswire/ -- OPEN Health, a
leading global provider of scientific communication and market
access services helping pharmaceutical companies to unlock the full
potential of their clinical and commercial assets, majority owned
by Astorg, has announced additions to its board of directors,
appointing David P. King as
non-executive chairman and Paul
Carter as an independent board member.
David P. King will be able to
draw on his extensive experience within the pharma services
industry to support OPEN Health's continued growth and
expansion.
"I am honored to be appointed chairman of OPEN Health, and I am
excited to partner with the management team and Astorg to support
strengthening its position as a global leader in medical affairs
and market access. OPEN Health's strong customer relationships and
deep commitment to science position it well for continued growth. I
look forward to working with OPEN Health's market-leading
management team as they continue to provide innovative solutions to
positively impact science, medicine, and patients' lives," remarked
David.
David P. King served for 13 years
as chairman and CEO of LabCorp, where he spearheaded the company's
transformation from a pure-play clinical laboratory into a global
leader in life sciences, tripling the size of the company to more
than $11.5 billion in revenue and
nearly 65,000 employees. David was critical in the expansion
of offerings for pharmaceutical and biotech companies, including
leading the acquisition of Covance. Today, LabCorp is a Fortune 250
company with over $15 billion in
revenue and 75,000 employees, serving pharmaceutical companies,
doctors, hospitals, researchers, and patients worldwide.
Paul Carter will draw on his
diverse commercial experience across multiple international markets
and leverage the pharma customer perspective to support OPEN
Health's continued dedication to science and customer
centricity.
Commenting on his appointment, Paul
Carter said, "OPEN Health is a formidable company, and I
look forward to working with the board and management team to help
guide the company's development plan and further strengthen its
position as a leading commercialization partner for pharma and
biotech companies globally."
Paul Carter served as executive
vice president and chief commercial officer at Gilead, where he
oversaw unprecedented growth and commercial success in the US,
Europe, Japan, and other geographies. In his prior
role as head of commercial operations for international markets at
Gilead, Mr. Carter built out the Gilead commercial infrastructure
across 38 countries over eight years.
"We are delighted to welcome Dave and Paul to the OPEN Health
board of directors, both stalwarts in the pharma ecosystem,"
Rob Barker, OPEN Health CEO, said.
"Dave and Paul are experienced leaders with excellent track records
in the healthcare and life sciences industry. Their leadership and
market insights will help OPEN Health to continue to grow and
scale."
Astorg partner and head of healthcare Judith Charpentier added, "Dave and Paul are
bringing a unique set of skills and knowledge drawing on decades of
experience and leadership in the healthcare ecosystem. As members
of the strong Astorg Healthcare leadership network, we have admired
Dave's and Paul's thought and market leadership for years, and we
are excited to have them join the OPEN Health board as independent
directors. The addition of their commercial and customer knowledge,
strong networks, and experience in growing companies will further
strengthen OPEN Health's market position."
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging
specialist expertise to unlock possibilities that improve health
outcomes and patient well-being. Working in partnership with our
clients, we embrace our different perspectives and strengths to
deliver fresh thinking and solutions that make a
difference. OPEN Health is a flexible global organization that
solves complex healthcare challenges across HEOR and market access,
medical communications and creative omnichannel campaigns. To
learn more, visit www.openhealthgroup.com.
About Astorg
Astorg is the majority shareholder of OPEN Health. A European
private equity firm with over €18 billion of assets under
management, Astorg works with entrepreneurs and management teams to
acquire market-leading global companies headquartered in
Europe or the US, providing them
with the strategic guidance, governance, and capital they need to
achieve their growth plans. Enjoying a distinct entrepreneurial
culture, a long-term shareholder perspective, and a lean
decision-making body, Astorg has valuable industry expertise in
healthcare, software, technology, business services, and
technology-based industrial companies. Astorg has offices in
London, Paris, New
York, Frankfurt,
Milan, and Luxembourg.
Logo -
https://mma.prnewswire.com/media/1586361/OH_Logo_Main_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/open-health-appoints-david-p-king-as-non-executive-chairman-and-paul-carter-as-independent-board-member-301686365.html